Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Françoise Durrieu

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
International Journal of Laboratory Hematology|November 9, 2022
Evaluation of the WBC-differential flagging performances and accuracy of the HORIBA Yumizen H2500 cell counter in oncology patients from a single institutionFrançoise Durrieu
Onkologie|February 8, 2012
Bone marrow metastases in a patient with primary mediastinal non-seminomatous germ cell tumor - an unusual pattern of relapseDelphine Garbay, Françoise Durrieu, Binh Bui, et al.
Cytometry. Part B, Clinical Cytometry|December 8, 2018
Acceptable "Real-Life" Variability for Lymphocyte Counts by Flow CytometryMichel Ticchioni, Chantal Brouzes, Françoise Durrieu, et al.
Annales De Biologie Clinique|December 14, 2018
Determination of acceptable limits of precision parameters for lymphocyte count by flow cytometryFrançoise Durrieu, Chantal Brouzes, Claude Lambert, et al.
Cytometry. Part B, Clinical Cytometry|August 27, 2009
Four- and five-color flow cytometry analysis of leukocyte differentiation pathways in normal bone marrow: a reference document based on a systematic approach by the GTLLF and GEILChristine Arnoulet, Marie C Béné, Françoise Durrieu, et al.
BMC Cancer|August 16, 2019
Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemiaMartin Gauthier, Françoise Durrieu, Elodie Martin, et al.
Haematologica|January 29, 2008
Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry methodNathalie Gachard, Aurélie Salviat, Catherine Boutet, et al.
British Journal of Haematology|September 11, 2018
CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiationAnna Raimbault, Sigrid Machherndl-Spandl, Raphaël Itzykson, et al.
International Journal of Environmental Research and Public Health|June 10, 2023
One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV StudyBrice Richez, Coralie Cantarel, Françoise Durrieu, et al.
Cancer Medicine|July 28, 2019
Incidence and outcome of BCR-ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitorsGabriel Etienne, Stéphanie Dulucq, Françoise Huguet, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Laboratory Hematology|November 9, 2022
Evaluation of the WBC-differential flagging performances and accuracy of the HORIBA Yumizen H2500 cell counter in oncology patients from a single institutionFrançoise Durrieu
Onkologie|February 8, 2012
Bone marrow metastases in a patient with primary mediastinal non-seminomatous germ cell tumor - an unusual pattern of relapseDelphine Garbay, Françoise Durrieu, Binh Bui, et al.
Cytometry. Part B, Clinical Cytometry|December 8, 2018
Acceptable "Real-Life" Variability for Lymphocyte Counts by Flow CytometryMichel Ticchioni, Chantal Brouzes, Françoise Durrieu, et al.
Annales De Biologie Clinique|December 14, 2018
Determination of acceptable limits of precision parameters for lymphocyte count by flow cytometryFrançoise Durrieu, Chantal Brouzes, Claude Lambert, et al.
Cytometry. Part B, Clinical Cytometry|August 27, 2009
Four- and five-color flow cytometry analysis of leukocyte differentiation pathways in normal bone marrow: a reference document based on a systematic approach by the GTLLF and GEILChristine Arnoulet, Marie C Béné, Françoise Durrieu, et al.
BMC Cancer|August 16, 2019
Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemiaMartin Gauthier, Françoise Durrieu, Elodie Martin, et al.
Haematologica|January 29, 2008
Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry methodNathalie Gachard, Aurélie Salviat, Catherine Boutet, et al.
British Journal of Haematology|September 11, 2018
CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiationAnna Raimbault, Sigrid Machherndl-Spandl, Raphaël Itzykson, et al.
International Journal of Environmental Research and Public Health|June 10, 2023
One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV StudyBrice Richez, Coralie Cantarel, Françoise Durrieu, et al.
Cancer Medicine|July 28, 2019
Incidence and outcome of BCR-ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitorsGabriel Etienne, Stéphanie Dulucq, Françoise Huguet, et al.
Pageof 2